Home
About
Publications Trends
Recent Publications
Expert Search
Archive
short chain fatty acids
What are Short Chain Fatty Acids?
Short chain fatty acids (SCFAs) are fatty acids with fewer than six carbon atoms. They are primarily produced by the microbial fermentation of dietary fibers in the colon. The most common SCFAs include acetate, propionate, and butyrate.
Frequently asked queries:
What are Short Chain Fatty Acids?
How are SCFAs Produced?
What is the Role of SCFAs in Cancer Prevention?
Can SCFAs be Used as a Treatment for Cancer?
How Do SCFAs Affect the Gut Microbiome?
What is the Mechanism of Action of SCFAs in Cancer Cells?
Are There Any Dietary Recommendations for Increasing SCFA Production?
What are the Challenges in Using SCFAs for Cancer Therapy?
What is the Future of SCFAs in Cancer Research?
What are the Benefits of Donating Through Your Will?
How is Module Detection Performed?
How Are Ambulatory Pumps Monitored?
Why Are Strong Passwords Important in Cancer Care?
How Does Gel Electrophoresis Help in Identifying Genetic Mutations?
What Are 'Silent' Cancers?
Why is Early Mobilization Important for Cancer Patients?
What is an Exercise Stress Test?
How Do Cancer Treatments Affect Morbidity?
What Mechanisms Lead to Telomerase Activation in Cancer?
Are There Long-term Effects of Lung Damage in Cancer Survivors?
Top Searches
Brain Tumor
Breast cancer
cancer
Cancer Genomics
Chemotherapy
hepatocellular carcinoma
Lung Cancer
Nanotechnology
Non-Hodgkin’s Lymphoma
Radiation-Induced Malignancies
Follow Us
Facebook
Linkedin
Youtube
Instagram
Partnered Content Networks
Relevant Topics
4D Segmentation
Alopecia
Atlas-based Segmentation
Automated Segmentation
B-cell malignancies
biomarkers
Brain Tumor
Brain Tumor Segmentation
Breast cancer
cancer
Cancer Genome Atlas
Cancer genomics
Cancer treatment
CAR T-cell therapy
Carcinogenesis
cell adhesion
cell migration
chemotherapy
Chromatin remodeling genes
Chronic inflammation
CIAbimatoprost
Co-morbidity
Combination therapy
Copy number variations
cytokine release syndrome
Deep Learning
Diagnosis challenges
diffuse large B-cell lymphoma
DNA damage
docetaxel-cyclophosphamide
Drug delivery
epirubicin-cyclophosphamide
extracellular matrix
Fibrosis
Genetic alteration
Glioblastoma
Gold nanoparticles
Hepatocellular carcinoma
High Tumor
image-guided radiotherapy
Imaging Techniques
Immunosuppression
Immunotherapy
Integrative genomics
integrin inhibitors
Integrins
intensity-modulated radiation therapy
Keratinocyte
Lipid-based nanoparticles
liver cancer
long-term cancer risks
Lung cancer
Machine Learning
Magnetic Resonance Imaging
metastasis
methyltransferase
MRI
Multi-modal Imaging
Multidisciplinary care
Mutual exclusivity analysis
Nanoparticles
Nanotechnology
neoadjuvant radiotherapy
neurotoxicity
Next-generation sequencing
nnovative Biomarkers
Non-Hodgkin’s lymphoma
Novel Biomarkers for Brain Tumors
Novel Chemotherapy
Oncogenic transcription factors
oncological diseases
paclitaxel
Personalized medicine
Photobiomodulation therapy
Polymeric nanoparticles
portal vein tumor thrombus
Probabilistic Models
proton therapy
Radiation-induced malignancies
radiotherapy
refractory lymphoma
relapsed lymphoma
Risk factors
secondary cancer prevention
secondary cancers
Silver nanoparticles
stereotactic body radiation therapy
Targeted therapy
Tolerability
transarterial chemoembolization
Tuberculosis
tumor microenvironment
tumor progression
Voltage-gated sodium channels
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Cancer.
Subscribe